Cleerly ISCHEMIA vs eMurmur ID
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a highly detailed, non-invasive assessment of coronary artery disease and vessel-level ischemia based on CCTA imaging. This tool is best suited for refining diagnosis and treatment planning for patients with suspected or known CAD, providing insights into plaque characteristics, stenosis severity, and estimated fractional flow reserve.
View Cleerly ISCHEMIA →Choose eMurmur ID if…
Choose eMurmur ID if you need an efficient, AI-powered solution for the rapid detection and classification of heart murmurs using an electronic stethoscope. This tool is ideal for primary care, telehealth, or initial cardiology screenings to quickly identify pathologic versus innocent murmurs and inform decisions on whether further advanced cardiac workup is necessary.
View eMurmur ID →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | eMurmur ID |
|---|---|---|
| Pricing | Contact for details | Unknown |
| Deployment | Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) | Cloud, Mobile, API integration |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur IDeMurmur ID offers a mobile app for recording and displaying heart sounds with real-time feedback, integrating directly with third-party electronic stethoscopes at the point of care. This provides a highly intuitive and accessible user experience for clinicians performing auscultation. Cleerly ISCHEMIA, while web-based with interactive reports, involves a more complex workflow around CCTA scan analysis and data transfer, which may be less immediate for point-of-care use.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA provides a comprehensive, AI-driven platform that quantifies and assesses coronary artery disease (CAD) by analyzing CCTA scans for non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood, and detailed plaque characterization. This offers a more granular and personalized approach to diagnosing and treatment planning for heart disease, with strong clinical validation against invasive FFR. eMurmur ID, while valuable for detecting and classifying heart murmurs, addresses a different, albeit important, aspect of cardiac assessment.
Pricing & Value
TieBoth tools explicitly state 'contact for details' or 'contact vendor' for their pricing information, offering no transparency. Without specific pricing or detailed value propositions beyond their features, it is impossible to conduct a meaningful comparison of their pricing and overall value.
Enterprise Readiness
eMurmur IDeMurmur ID explicitly states it is HIPAA compliant, has a Business Associate Agreement (BAA), and offers flexible deployment options including mobile, cloud (SaaS), on-premise, and hybrid. It also mentions integrations with EHRs, PACS, and other systems. Cleerly ISCHEMIA is also HIPAA compliant and has a BAA, and integrates with PowerScribe, but eMurmur ID's broader stated deployment flexibility and integration capabilities suggest a slightly stronger enterprise readiness.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA's application of AI to CCTA for non-invasive fractional flow reserve (FFR) estimation, detailed plaque characterization (volume, type, location), and 3D digital models of coronary arteries represents a highly advanced and complex diagnostic innovation. This technology aims to redefine the standard of care for heart disease diagnosis by providing comprehensive insights from a single non-invasive test. While eMurmur ID's real-time AI-powered murmur detection via stethoscopes is innovative for point-of-care screening, Cleerly's depth of analysis in cardiac imaging is more groundbreaking.
Support & Docs
TieNeither the provided structured facts nor general web searches yielded specific details regarding the quality, availability, or scope of support and documentation for either Cleerly ISCHEMIA or eMurmur ID. Therefore, it is not possible to distinguish between the two tools on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | eMurmur ID |
|---|---|---|
| Tool Name | Cleerly ISCHEMIA | eMurmur ID |
| Company | Cleerly | CSD Labs GmbH |
| Primary Input Data | CCTA scans | Heart sounds using a third-party electronic stethoscope |
| Core Analysis Output | Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination | AI-based analytics for heart murmur detection and classification |
| Specific Diagnostic Capability | Determines likelihood of coronary artery ischemia at a vessel level, coronary plaque characterization (volume, type, location), stenosis severity assessment | Identifies pathologic and innocent heart murmurs, absence of murmur, S1, S2 heart sounds |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and eMurmur ID.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or eMurmur ID
Backers
Who funded each tool's parent company.